D. Healy

H. Burger, B. Vollenhoven, G. Kovacs, 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Treatment of anovulation due to polycystic ovarian syndrome by laparoscopic ovarian electrocautery

H. Burger, G. Baker, G. Kovacs, 1991, British journal of obstetrics and gynaecology.

Cancer risks associated with the diagnosis of infertility.

A. Venn, R. Mclachlan, D. Healy, 2003, Best practice & research. Clinical obstetrics & gynaecology.

Fertility drugs and cancer

A. Venn, D. Healy, 1997 .

Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations.

I. Cameron, D. D. de Kretser, F. O'Shea, 1988, The Journal of clinical endocrinology and metabolism.

Advances in reproductive medicine: Australian contributions.

H. Burger, H. Baker, G. Kovacs, 1988, Australian and New Zealand journal of medicine.

Review: Human Prolactin ‐ Recent Advances in Physiology and Therapy

H. Burger, D. Healy, D. Healy, 1977, The Australian & New Zealand journal of obstetrics & gynaecology.

Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology.

R. Koistinen, M. Seppälä, V. Maclachlan, 1996, Fertility and sterility.

Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment.

C. Wood, V. Maclachlan, D. Healy, 1998, Fertility and sterility.

Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.

A. Herington, B. Vollenhoven, D. Healy, 1993, The Journal of clinical endocrinology and metabolism.

An open study of luteinizing hormone releasing hormone agonists in infertile women with uterine fibroids.

B. Vollenhoven, P. Mccloud, D. Healy, 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Pelvic Pain Complicating LHRH Analogue Treatment of Fibroids

T. Chipato, B. Vollenhoven, D. Healy, 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

Management of submucous uterine fibroid with buserelin, gemeprost and hysteroscopic resection

D. Hill, D. Healy, A. S. Lawrence, 1991, The Medical journal of Australia.

Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.

B. Vollenhoven, D. Healy, P. Shekleton, 1990, Fertility and sterility.

Excessive angiogenesis: a new theory for endometriosis

P. Rogers, C. Gargett, D. Healy, 1998 .

Ovarian status in healthy postmenopausal women

M. Oehler, R. Bell, D. Robertson, 2008, Menopause.

Vascular smooth muscle cell proliferation in arterioles of the human endometrium.

P. Rogers, P. Rogers, K. Abberton, 1999, Human reproduction.

Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.

P. Rogers, K. Abberton, D. Healy, 1999, Human reproduction.

Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.

P. Rogers, D. Healy, N. Taylor, 1996, Human reproduction.

Vascular smooth muscle alpha-actin distribution around endometrial arterioles during the menstrual cycle: increased expression during the perimenopause and lack of correlation with menorrhagia.

P. Rogers, K. Abberton, D. Healy, 1996, Human reproduction.

Endometrial sex steroid receptor expression in women with menorrhagia

P. Rogers, H. Critchley, K. Abberton, 1994, British journal of obstetrics and gynaecology.

The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells.

I. Cameron, M. Cameron, D. Baird, 1986, The Journal of clinical endocrinology and metabolism.

Morphologic response of endometrium to a progesterone receptor antagonist, RU486, in monkeys.

G. Hodgen, D. Healy, M. J. Koering, 1986, Fertility and sterility.

RU 486 Stimulation of PGF2-Alpha Production in Isolated Endometrial Cells in Short Term Culture

I. Cameron, M. Cameron, D. Baird, 1985 .

Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.

E. Margalioth, D. Robertson, Y. Diamant, 2002, Human reproduction.

Ovarian status in healthy postmenopausal women: follow-up 12 months after transvaginal ultrasound

M. Oehler, R. Bell, D. Robertson, 2009, Menopause.

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

A. Venn, G. Giles, J. Lumley, 1995, The Lancet.

INCREASED PROLACTIN AND THYROTROPHIN SECRETION FOLLOWING ORAL METOCLOPRAMIDE: DOSE‐RESPONSE RELATIONSHIPS

H. Burger, D. Healy, D. Healy, 1977, Clinical endocrinology.

Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.

E. Baulieu, G. Hodgen, D. Healy, 1983, Fertility and sterility.

Maternal, Umbilical, and Amniotic Fluid Concentrations of Tryptophan and Kynurenine after Labor or Cesarean Section

D. Healy, H. Kazda, N. Taylor, 1998, Pediatric Research.

Damaged babies from assisted reproductive technologies: focus on the BESST (birth emphasizing a successful singleton at term) outcome.

D. Healy, 2004, Fertility and sterility.

What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

V. Maclachlan, D. Healy, J. Min, 2004, Human reproduction.

High frequency of cesarean section, antepartum hemorrhage, placenta previa, and preterm delivery in in-vitro fertilization twin pregnancies.

J. Halliday, D. Healy, S. Breheny, 2003, Fertility and sterility.

Inhibins/activins as diagnostic markers for ovarian cancer

H. Burger, N. Groome, D. Robertson, 2002, Molecular and Cellular Endocrinology.

Perinatal Outcomes after Assisted Reproductive Technology Treatment in Australia and New Zealand: Single versus Double Embryo Transfer

E. Sullivan, Y. Wang, D. Healy, 2009 .

Characteristics of an antiluteinizing hormone isoantibody produced during gonadotropin induction of ovulation.

H. Burger, I. Fraser, D. Healy, 1978, The Journal of clinical endocrinology and metabolism.

Sustained elevation of serum prolactin by metoclopramide: a clinical model of idiopathic hyperprolactinemia.

H. Burger, D. Healy, 1978, The Journal of clinical endocrinology and metabolism.

Ovine trophoblast protein-1 and human interferon alpha reduce prostaglandin synthesis by ovine endometrial cells.

L. Salamonsen, J. Findlay, D. Healy, 1989, Prostaglandins.

Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.

H. Burger, R. Mclachlan, V. Maclachlan, 1988, The Journal of clinical endocrinology and metabolism.

Pulsatile progesterone secretion: its relevance to clinical evaluation of corpus luteum function.

R. Schenken, G. Hodgen, D. Healy, 1984, Fertility and sterility.

Prolactin in human milk: correlation with lactose, total protein, and alpha-lactalbumin levels.

H. Burger, P. Hartmann, A. Herington, 1980, The American journal of physiology.

Replacement of one selected embryo is just as successful as two embryo transfer, without the risk of twin pregnancy

L. Rombauts, G. Kovacs, V. Maclachlan, 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

Mifepristone: an overview for Australian practice

D. Healy, 2009 .

Safety of post-menopausal hormone replacement.

H. Critchley, D. Healy, E. Farrell, 1992, Australian and New Zealand journal of medicine.

Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins

H. Burger, B. Vollenhoven, D. Healy, 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

D. Connolly, P. Rogers, N. Mcclure, 1994, The Lancet.

Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.

H. Burger, P. Mamers, T. Jobling, 1995, Gynecologic oncology.

A prospective study of inhibin in granulosa cell tumors of the ovary.

H. Burger, M. Quinn, P. Mamers, 1994, Gynecologic oncology.

Inhibin and ovarian cancer.

H. Burger, N. Groome, P. Fuller, 1998, Journal of reproductive immunology.

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.

H. Burger, M. Quinn, J. Campbell, 1994, The New England journal of medicine.

Clinical and pathophysiological aspects of inhibin.

H. Burger, P. Mamers, D. Healy, 1993, Human reproduction.

THE MATERNAL OVARY IS NOT THE SOURCE OF CIRCULATING INHIBIN LEVELS DURING HUMAN PREGNANCY

H. Burger, J. Findlay, D. Healy, 1987, Clinical endocrinology.

Circulating immunoreactive inhibin levels during the normal human menstrual cycle.

H. Burger, D. Robertson, D. D. de Kretser, 1987, The Journal of clinical endocrinology and metabolism.

Methode de depistage, de prophylaxie et/ou de traitement de maladies affectant l'homme

N. Mcclure, D. Healy, David Mark Milne-Roberts, 1994 .

Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent.

J. Findlay, D. Healy, L. Shukovski, 1989, The Journal of clinical endocrinology and metabolism.

Induction of ovulation with human pituitary gonadotropin: Twelve years’ experience

H. Burger, G. Kovacs, D. Healy, 1984, The Medical journal of Australia.

Pregnancies complicated by abnormally adherent placenta and sex ratio at birth.

T. Khong, P. Mccloud, D. Healy, 1991, BMJ.

6 Endometrial prolactin and implantation

D. Healy, 1991 .

Presence of pro-opiomelanocortin peptides and corticotropin-releasing factor in human placenta.

J. Funder, M. Fullerton, M. Ng, 1996, The Malaysian journal of pathology.

The progesterone antagonist RU 486. A potential new contraceptive agent.

G. Chrousos, E. Baulieu, G. Merriam, 1987 .

Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships.

G. Chrousos, H. Schulte, P. Gold, 1985, The Journal of clinical endocrinology and metabolism.

3 Inhibin and related peptides in pregnancy

D. Healy, D. Kretser, D. Polson, 1990 .

Inhibin: Circulating Levels in Women during Ovulation Induction and Detection in Human Placenta by Specific Radioimmunoassay a

H. Burger, D. Robertson, D. D. de Kretser, 1988, Annals of the New York Academy of Sciences.

Circulating immunoactive inhibin in the luteal phase and early gestation of women undergoing ovulation induction.

H. Burger, D. Robertson, D. D. de Kretser, 1987, Fertility and sterility.

FSH-regulated gene expression profiles in ovarian tumours and normal ovaries.

H. Burger, S. Chu, P. Fuller, 2002, Molecular human reproduction.

Pituitary and adrenal responses to the anti-progesterone and anti-glucocorticoid steroid RU 486 in primates.

G. Chrousos, E. Baulieu, H. Schulte, 1983, The Journal of clinical endocrinology and metabolism.

Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle

H. Burger, G. Kovacs, D. Healy, 1991, Clinical endocrinology.

Non-Human Primate Studies with RU 486

G. Hodgen, D. Healy, 1985 .

Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.

H. Burger, I. Cameron, D. Healy, 1988, The Journal of clinical endocrinology and metabolism.

A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.

C. Wood, V. Maclachlan, D. Healy, 1991, Fertility and sterility.

Do raised serum luteinizing hormone levels during stimulation for in‐vitro fertilization predict outcome?

A. Thomas, V. Maclachlan, M. Besanko, 1989, British journal of obstetrics and gynaecology.

A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.

A. Trounson, C. Wood, V. Maclachlan, 1989, The New England journal of medicine.

Cross-over trial of superovulation protocols from two major in vitro fertilization centers.

A. Trounson, C. Wood, A. Thomas, 1986, Fertility and sterility.

Pulsatile progesterone secretion: its relevance to clinical evaluation of corpus luteum function

R. Schenken, G. Hodgen, D. Healy, 1984 .

Female infertility: causes and treatment

A. Trounson, A. Andersen, D. Healy, 1994, The Lancet.

Outcomes of singleton births after blastocyst versus nonblastocyst transfer in assisted reproductive technology.

J. Halliday, D. Healy, S. Breheny, 2012, Fertility and sterility.

Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme.

H. Burger, G. Baker, B. Vollenhoven, 1997, Human reproduction.

The human placenta: a novel source of inhibin.

H. Burger, D. Robertson, D. D. de Kretser, 1986, Biochemical and biophysical research communications.

A water control device for mounting serial ultrathin sections.

J. A. Westfall, D. Healy, 1962, Stain technology.

Oocyte and Embryo Donation in Women with Absent Ovarian Function

I. Kola, A. Trounson, J. Findlay, 1987 .

Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.

N. Groome, D. Robertson, V. Maclachlan, 2000, The Journal of clinical endocrinology and metabolism.

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

A. Venn, J. Lumley, L. Watson, 1995, The Lancet.

A comparison of pregnancy rates for 131 donor oocyte transfers using either a sequential or fixed regime of steroid replacement therapy.

J. Leeton, D. Healy, P. Rogers, 1991, Human reproduction.

Oocyte donation: a review

J. Leeton, D. Healy, J. Harman, 1989, British journal of obstetrics and gynaecology.

Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies.

O. Ukoumunne, D. Amor, J. Halliday, 2010, Fertility and sterility.

Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.

A. Venn, M. Quinn, M. Quinn, 2001, Gynecologic oncology.

Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia.

J. Halliday, H. Baker, D. Healy, 2010, Human reproduction.

Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies.

O. Ukoumunne, D. Amor, J. Halliday, 2010, Human reproduction.

Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.

D. Amor, J. Halliday, H. Baker, 2009, Human reproduction.

Early pregnancy Increased risk of blastogenesis birth defects , arising in the first 4 weeks of pregnancy , after assisted reproductive technologies

O. Ukoumunne, D. Amor, J. Halliday, 2009 .

Early pregnancy Pregnancies conceived using assisted reproductive technologies ( ART ) have low levels of pregnancy-associated plasma protein-A ( PAPPA ) leading to a high rate of false-positive results in first trimester screening for Down syndrome

D. Amor, J. Halliday, H. Baker, 2009 .

Mortality in a cohort of IVF patients.

A. Venn, L. Watson, E. Hemminki, 2001, Human reproduction.

Contributions of in vitro fertilization to knowledge of the reproductive endocrinology of the menstrual cycle.

A. Thomas, M. Besanko, L. Morrow, 1987, Bailliere's clinical endocrinology and metabolism.

An analysis of plasma estradiol concentrations during clomiphene citrate-human menopausal gonadotropin stimulation in an in vitro fertilization-embryo transfer program.

E. C. Wood, A. Trounson, J. Leeton, 1986, The Journal of clinical endocrinology and metabolism.

The Clinical Significance of Endometrial Prolactin

D. Healy, 1984, The Australian & New Zealand journal of obstetrics & gynaecology.

Prostaglandins and Progesterone Receptor Antagonists in Human Fertility Regulation

D. Healy, 1994, The Australian & New Zealand journal of obstetrics & gynaecology.

Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.

D. Healy, 1990, Reproduction, fertility, and development.

5 Anti-progesterones: background and clinical physiology

I. Cameron, D. Healy, 1988 .

Pituitary Responses to Acute Administration of Thymosin and to Thymectomy in Prepubertal Primates

G. Chrousos, H. Schulte, A. Goldstein, 1984 .

Inhibins and activins: roles in clinical practice

E. Wallace, D. Healy, 1996, British journal of obstetrics and gynaecology.

Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors

H. Burger, M. Quinn, J. Campbell, 1993 .

Concentrations of immunoactive inhibin in serum during human pregnancy: evidence for an ovarian contribution.

D. D. de Kretser, P. Mamers, D. Healy, 1991, Reproduction, fertility, and development.

Inhibin and the human placenta: a critique.

T. Khong, J. Findlay, D. D. de Kretser, 1991, Reproduction, fertility, and development.

Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome.

David Handelsman, D. Robertson, D. D. de Kretser, 1990, The Journal of clinical endocrinology and metabolism.

D. D. de Kretser, D. Healy, D. Polson, 1990, Bailliere's clinical endocrinology and metabolism.

Serum follicle-stimulating hormone, luteinizing hormone, and prolactin during the induction of ovulation with exogenous gonadotropin.

H. Burger, D. Healy, 1983, The Journal of clinical endocrinology and metabolism.

Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer.

E. C. Wood, A. Trounson, L. Morrow, 1987, British medical journal.

Comparison of inhibin immunological and in vitro biological activities in human serum.

David Handelsman, D. Baird, D. Robertson, 1988, The Journal of clinical endocrinology and metabolism.

A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility.

J. Leeton, D. Healy, C. Yates, 1987, Fertility and sterility.

One triplet pregnancy in 510 controlled ovarian hyperstimulation and intrauterine insemination cycles.

B. Vollenhoven, L. Rombauts, G. Kovacs, 2003, Fertility and sterility.

The thymus-adrenal connection: thymosin has corticotropin-releasing activity in primates.

G. Chrousos, H. Schulte, A. Goldstein, 1983, Science.

Human cloning 2001

A. Trounson, M. Pera, G. Weston, 2002, Human fertility.

Progesterone in vitro stimulates secretion of a specific protein by ovine epithelial endometrial cells.

L. Salamonsen, J. Findlay, D. Healy, 1987, Journal of steroid biochemistry.

A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage

J. Shelley, S. Grover, D. Healy, 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

Endometrial ablation: an option for the management of menstrual problems in the intellectually disabled

M. Wingfield, D. Healy, 1994, The Medical journal of Australia.

Gynaecological care for women with intellectual disability

D. Healy, M. Wingfield, A. Nicholson, 1994, The Medical journal of Australia.

Endometriosis Science and Practice

L. Giudice, D. Healy, J. Evers, 2011 .

Review of major complications of laparoscopy in a free‐standing gynaecological day case hospital

D. Healy, J. Tsaltas, D. Lloyd, 1996 .

Effective Gynecological Day Surgery

D. Healy, O. Petrucco, 1998 .

Cell proliferation is increased in the endometrium of women with endometriosis.

P. Rogers, P. Rogers, M Wingfield, 1995, Fertility and sterility.

Preterm birth, ovarian endometriomata, and assisted reproduction technologies.

G. Baker, J. Halliday, D. Healy, 2009, Fertility and sterility.

Follow-up of children born after in-vitro fertilisation

D. Healy, K. Saunders, 2002, The Lancet.

Inhibin subunit gene expression in ovarian cancer.

H. Burger, S. Chu, P. Fuller, 1999, Gynecologic oncology.

A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety of Vaginal Recombinant Human Relaxin for Cervical Ripening

S. Brennecke, M. Permezel, R. Bell, 1993, Obstetrics and gynecology.

Cloning: its relevance to monozygotic twins

A. Trounson, G. Weston, D. Healy, 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

Messenger RNA encoding the insulin-like growth factors and their binding proteins, in women with fibroids, pretreated with luteinizing hormone-releasing hormone agonists.

A. Herington, B. Vollenhoven, D. Healy, 1994, Human reproduction.

A normal cumulative conception rate after human pituitary gonadotropin.

H. Burger, R. Pepperell, G. Kovacs, 1980, Fertility and sterility.

Use of single doses of the antiprogesterone steroid RU 486 for induction of menstruation in normal women.

G. Chrousos, L. Nieman, C. Bardin, 1985 .

The endocrinology of human endometrium.

G. Hodgen, D. Healy, 1983, Obstetrical & gynecological survey.

PLASMA INHIBIN LEVELS DURING GONADOTROPIN-INDUCED OVARIAN HYPERSTIMULATION FOR IVF: A NEW INDEX OF FOLLICULAR FUNCTION?

H. Burger, D. Robertson, D. Kretser, 1986, The Lancet.

Inhibins and activins in reproduction

L. Rombauts, D. Healy, 1995 .

Generating receptive endometrium in Asherman's syndrome

C. Gargett, D. Healy, 2011, Journal of human reproductive sciences.

Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome.

H. Burger, D. Healy, H. Buckler, 1992, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Laparoscopic and abdominal hysterectomy: a cost comparison

D. Healy, J. Tsaltas, 1997, The Medical journal of Australia.

7 Other medical management of uterine fibroids

D. Healy, T. Eldar‐Geva, 1998 .

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.

R. Norman, L. Rombauts, D. Healy, 2006, Human reproduction.

Cumulative pregnancy and live birth rates after gamete intra-Fallopian transfer.

L. Rombauts, D. Healy, S. Breheny, 1997, Human reproduction.

Genomics in obstetrics and gynaecology

B. Vollenhoven, G. Weston, A. Ponnampalam, 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

SERUM PROLACTIN LEVELS AND THE VALUE OF BROMOCRIPTINE IN THE TREATMENT OF ANOVULATORY INFERTILITY

H. Burger, J. Brown, R. Pepperell, 1977, British journal of obstetrics and gynaecology.

Immune Regulation of the Hypothalamic-Hypophysial-Adrenal Axis: A Role for Thymosins and Lymphokines

A. Goldstein, D. Healy, N. Hall, 1984 .

Short- and long-term effects of ovulation induction.

B. Vollenhoven, D. Healy, 1998, Endocrinology and metabolism clinics of North America.

Mid‐Cavity Occipitoanterior Forceps Delivery — Laufe and Barnes Forceps Compared

D. Healy, Brett J. Marshall, 1987, The Australian & New Zealand journal of obstetrics & gynaecology.

Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.

H. Burger, W. Bremner, R. Pepperell, 1977, The Journal of clinical endocrinology and metabolism.

9 Endometriosis: Medical therapy

M. Wingfield, D. Healy, 1993 .

Hypothesis: Placental membranes produce prolactin

H. Burger, H. Muller, D. Healy, 1978, Molecular and Cellular Endocrinology.

Laparoscopic and abdominal hysterectomy: a cost comparison

P. Mamers, D. Healy, A. Magnus, 1997 .

Depot Goserelin and Danazol Pre‐Treatment Before Rollerball Endometrial Ablation for Menorrhagia

I S Fraser, P. Mamers, D L Healy, 1996, Obstetrics and gynecology.

Survey of obstetric forceps training in North America in 1981.

L. Laufe, D. Healy, 1985, American journal of obstetrics and gynecology.

Rotational delivery of the fetus: Kielland's forceps and two other methods compared

R. Pepperell, M. Quinn, D. Healy, 1982, British journal of obstetrics and gynaecology.

Is the luteo-placental shift a myth? Analysis of low progesterone levels in successful art pregnancies.

V. Maclachlan, M. Besanko, D. Healy, 1993, The Journal of clinical endocrinology and metabolism.

The presence of lactogen receptors in human chorion laeve.

A. Herington, D. Healy, J. Graham, 1980, The Journal of clinical endocrinology and metabolism.

Chronic polyhydramnios is a syndrome with a lactogen receptor defect in the chorion laeve

C. O'Herlihy, A. Herington, D. Healy, 1985, British journal of obstetrics and gynaecology.

Chronic idiopathic polyhydramnios: evidence for a defect in the chorion laeve receptor for lactogenic hormones.

C. O'Herlihy, A. Herington, D. Healy, 1983, The Journal of clinical endocrinology and metabolism.

Immunomodulatory peptides and the central nervous system

A. Goldstein, D. Healy, N. Hall, 2004, Springer Seminars in Immunopathology.

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

T. Strowitzki, M. Germond, E. Loumaye, 1999, Human Reproduction.

Lupus anticoagulant in women with multiple spontaneous miscarriage

D. Healy, B. Firkin, M. Howard, 1987, American journal of hematology.

Australian Collaborative Trial of Antenatal Thyrotropin-Releasing-Hormone (Actobat) for Prevention of Neonatal Respiratory-Disease

S. Brennecke, L. Doyle, M. Rowley, 1995 .

Active cutaneous anaphylaxis in the guinea-pig. Immunological and inflammatory reactions.

H. Muller, D. Healy, 1973, Immunology.

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.

D. Healy, F. Cattrall, Fleur R Cattrall, 2004, Best practice & research. Clinical obstetrics & gynaecology.

Infertility Therapies: The Role of Surgery

D. Healy, O. Petrucco, 2012 .

Randomized controlled trial of postoperative pain and activity following microlaparoscopy and standard laparoscopy

C. Goodchild, P. Mamers, D. Healy, 2000 .

Impact of uterine fibroids on ART outcome.

D. Healy, 2000, Environmental health perspectives.

Relaxin in sera during the luteal phase of in‐vitro fertilization cycles

G. Tregear, R. Bell, D. Healy, 1990, British journal of obstetrics and gynaecology.

Relaxin levels in antenatal patients following in vitro fertilization.

G. Tregear, R. Bell, D. Healy, 1989, Fertility and sterility.

Different influence of incongruent follicular development on in vitro fertilization-embryo transfer and gamete intrafallopian transfer pregnancy rates.

L. Rombauts, V. Maclachlan, D. Healy, 1998, Fertility and sterility.

Incongruent follicular development reduces gamete intrafallopian transfer pregnancy rate.

C. Wood, L. Rombauts, D. Healy, 1996, Fertility and sterility.

Does gonadotropin suppression result in follicular development in premature ovarian failure?

H. Burger, D. Healy, H. Buckler, 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Embryo transfer: hysteroscopic assessment of transfer catheter effects on the endometrium.

L. Rombauts, D. Healy, A. Murray, 2003, Reproductive Biomedicine Online.

Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment.

D. Robertson, D. Healy, J. Moohan, 1995, Human reproduction.

Ignorance of electrosurgery among obstetricians and gynaecologists

L. Rombauts, D. Healy, J. Tsaltas, 2004, BJOG: an International Journal of Obstetrics and Gynaecology.

Aetiology, investigation and management of ovulatory problems

D. Healy, 1992 .

Author's reply

D. Healy, 1990 .

Low intraovarian vascular resistance: a marker for severe ovarian hyperstimulation syndrome.

D. Healy, K. Curcio, J. Moohan, 1997, Fertility and sterility.

Age-specific success rate for women undertaking their first assisted reproduction technology treatment using their own oocytes in Australia, 2002-2005.

E. Sullivan, D. Healy, D. Black, 2008, Human reproduction.

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.

A. Pellicer, A. Leader, J. García-Velasco, 1999, Human reproduction.

Pregnancy results following embryo transfer in women receiving low-dosage variable-length estrogen replacement therapy for premature ovarian failure

I. Cameron, J. Leeton, D. Healy, 1989, Journal of in Vitro Fertilization and Embryo Transfer.

Purified FSH stimulates production of inhibin by the human ovary.

H. Burger, D. Healy, H. Buckler, 1989, The Journal of endocrinology.

Thymic regulation of primate fetal ovarian-adrenal differentiation.

G. Hodgen, J. Bacher, D. Healy, 1985, Biology of reproduction.

Occult Ovarian Failure

D. Healy, 1991, Annals of the New York Academy of Sciences.

Phytoestrogens and breast cancer in postmenopausal women: a case control study

E. Briganti, H. Burger, M. Wahlqvist, 2000, Menopause.

Relaxin levels in antenatal patients following in vitro fertilization

G. Tregear, R. Bell, D. Healy, 1989 .

Activin‐A secretion is increased in the eutopic endometrium from women with essndometriosis

J. Donoghue, L. Rombauts, Rebecca L. Jones, 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

Optimizing outcome in assisted reproduction reducing multiple pregnancy

L. Rombauts, G. Kovacs, V. Maclachlan, 2004 .

Corticotropin releasing hormone- and adreno-corticotropin-like immunoreactivity in human placenta, peripheral and uterine vein plasma.

H. Schulte, D. Healy, 1987, Hormone and metabolic research. Supplement series.

Infertility medications and the risk of breast cancer.

A. Venn, D. Healy, 2003, Fertility and sterility.

Reliability and validity of an objective assessment instrument of laparoscopic skill.

L. Rombauts, D. Healy, J. Tsaltas, 2004, Fertility and sterility.

AAGL 3rd InternAtIonAL ConGress on MInIMALLy InvAsIve GyneCoLoGy

K. Karthigasu, H. Merkur, M. McEvoy, 2009 .

Ovarian relaxin is not essential for dilatation of cervix

I. Cameron, J. Leeton, P. Renou, 1990, The Lancet.

Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia.

P. Rogers, D. Healy, F. Lederman, 1996, Human reproduction.

A STUDY OF THE EFFECTS OF BROMOCRIPTINE ON SERUM PROLACTIN, FOLLICLE STIMULATING HORMONE AND LUTEINIZING HORMONE AND ON OVARIAN RESPONSIVENESS TO EXOGENOUS GONADOTROPHINS IN ANOVULATORY WOMEN

James B. Brown, H. Burger, J. Brown, 1977, British journal of obstetrics and gynaecology.

Ovarian cancer in infertility patients.

D. Healy, L. Burmeister, Lynette Burmeister, 1998, Annals of medicine.

Basics of ovarian stimulation

G. Baker, V. Maclachlan, D. Healy, 2007 .

Prevention of multiple gestation in controlled ovarian stimulation: Introduction to Theme

D. Healy, 2006 .

Induction of ovulation with gonadotrophin‐releasing hormone — life‐table analysis of 50 courses of treatment

H. Burger, G. Kovacs, D. Healy, 1989, The Medical journal of Australia.

Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle.

H. Burger, P. Mccloud, D. Healy, 1993, The Journal of clinical endocrinology and metabolism.

Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer.

D. Robertson, D. D. de Kretser, V. Maclachlan, 1993, Fertility and sterility.

Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?

H. Burger, N. Mcclure, G. Kovacs, 1992, Fertility and sterility.

Inhibins and ovarian cancer

H. Burger, D. Robertson, T. Jobling, 2004, Molecular and Cellular Endocrinology.

Image analysis quantification of the Miles assay.

N. Mcclure, D. Robertson, D. Healy, 1994, Journal of pharmacological and toxicological methods.

PLASMA INHIBIN LEVELS DURING GONADOTROPIN-INDUCED OVARIAN HYPERSTIMULATION FOR IVF: A NEW INDEX OF FOLLICULAR FUNCTION?

H. Burger, D. Robertson, D. Kretser, 1986, The Lancet.

PLASMA INHIBIN LEVELS DURING GONADOTROPIN-INDUCED OVARIAN HYPERSTIMULATION FOR IVF: A NEW INDEX OF FOLLICULAR FUNCTION?

H. Burger, D. Robertson, D. Kretser, 1986, The Lancet.

Immunofluorescence shows localisation of prolactin to human amnion

H. Burger, H. Muller, D. Healy, 1977, Nature.

Plasma inhibin levels during gonadotropin‐induced ovarian hyperstimulation for IVF: A new index of follicular function?

D. Robertson, D. Healy, R. McLachlan, 1987 .

Is ovarian relaxin a stimulus to placental protein 14 secretion in pregnancy?

T. Chard, D. Healy, H. Critchley, 1994, Journal of Endocrinology.

Other medical management of uterine fibroids.

D. Healy, T. Eldar‐Geva, 1998, Bailliere's clinical obstetrics and gynaecology.

Endocrinology and paracrinology: Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment

D. Robertson, D. Healy, J. Moohan, 1995 .

Perinatal outcomes after assisted reproductive technology treatment in Australia and New Zealand: single versus double embryo transfer

Y. Wang, D. Healy, D. Black, 2009, The Medical journal of Australia.

Production of Inhibin-Related Peptides by Ovarian Tumors

H. Burger, D. Robertson, P. Mamers, 1997 .

Oocyte donation and in vitro fertilization for hypergonadotropic hypogonadism: clinical state of the art.

E. C. Wood, I. Cameron, A. Trounson, 1987, Obstetrical & gynecological survey.